• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度社区人群中按年龄划分的前列腺特异性抗原及前列腺特异性抗原密度值

Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population.

作者信息

Ganpule Arvind P, Desai Mahesh R, Manohar T, Bapat Sharad

机构信息

Department of Urology, Muljibhai Patel Urological Hospital, Dr. V. V. Desai Road, Nadiad, Gujarat, India.

出版信息

Indian J Urol. 2007 Apr;23(2):122-5. doi: 10.4103/0970-1591.32060.

DOI:10.4103/0970-1591.32060
PMID:19675786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2721518/
Abstract

INTRODUCTION

We sought to determine the distribution of serum prostate specific antigen (PSA) levels in a community-based population in the state of Gujarat in India.

MATERIALS AND METHODS

Community screening of subjects residing in Kheda and Anand districts of Gujarat was done with digital rectal examination (DRE), uroflowmetry and transabdominal sonography and serum PSA. In three villages transrectal sonography was done in addition to transabdominal sonography. All patients with a PSA of more than 4 ng/ml and / or abnormal DRE were evaluated. Biopsy-proven prostatic malignancy was detected in 20 patients. Subjects who did not follow up and who had biopsy-proven malignancy were excluded from the analysis, 1899 subjects were analyzed.

RESULTS

One thousand seven hundred and eighty-seven (89.17%) had a PSA of <4 ngml, 180 (8.9%) had a PSA between 4-10 ng/ml, while 37 (1.8 %) had a PSA more than 10ng/ml. There was a statistically significant correlation between age and prostate volume (correlation coefficient 0.33) and between prostate volume and PSA (correlation coefficient 0.50). The age-specific PSA values derived as the 95(th) percentile value were as follows, 40-49 years (0-2.1), 50-59 years (0-3.4), 60-69 years (0-4.2) and more than 70 years (0-5.0). The 95(th) percentile value for PSAD was 0.19.

CONCLUSION

Indians need to have separate PSA reference ranges. The age-specific PSA ranges for men in the present study population are on the lower side and the prostate specific antigen density on the higher side.

摘要

引言

我们试图确定印度古吉拉特邦一个社区人群的血清前列腺特异性抗原(PSA)水平分布情况。

材料与方法

对居住在古吉拉特邦凯达和阿南德地区的受试者进行社区筛查,检查项目包括直肠指诊(DRE)、尿流率测定、经腹超声检查以及血清PSA检测。在三个村庄,除经腹超声检查外还进行了经直肠超声检查。对所有PSA大于4 ng/ml和/或直肠指诊异常的患者进行评估。经活检证实有前列腺恶性肿瘤的患者共20例。未进行随访以及经活检证实有恶性肿瘤的受试者被排除在分析之外,最终对1899名受试者进行了分析。

结果

1787名(89.17%)受试者的PSA<4 ng/ml,180名(8.9%)受试者的PSA在4 - 10 ng/ml之间,而37名(1.8%)受试者的PSA大于10 ng/ml。年龄与前列腺体积之间(相关系数0.33)以及前列腺体积与PSA之间(相关系数0.50)存在统计学显著相关性。以第95百分位数得出的年龄特异性PSA值如下:40 - 49岁(0 - 2.1),50 - 59岁(0 - 3.4),60 - 69岁(0 - 4.2)以及70岁以上(0 - 5.0)。PSAD的第95百分位数为0.19。

结论

印度人需要有单独的PSA参考范围。本研究人群中男性的年龄特异性PSA范围较低,而前列腺特异性抗原密度较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/2721518/18d2d8d865b7/IJU-23-122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/2721518/fc4b5cdcd74b/IJU-23-122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/2721518/d0f38bc7c0f4/IJU-23-122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/2721518/435b6e5a32d5/IJU-23-122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/2721518/18d2d8d865b7/IJU-23-122-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/2721518/fc4b5cdcd74b/IJU-23-122-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/2721518/d0f38bc7c0f4/IJU-23-122-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/2721518/435b6e5a32d5/IJU-23-122-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9814/2721518/18d2d8d865b7/IJU-23-122-g004.jpg

相似文献

1
Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population.印度社区人群中按年龄划分的前列腺特异性抗原及前列腺特异性抗原密度值
Indian J Urol. 2007 Apr;23(2):122-5. doi: 10.4103/0970-1591.32060.
2
The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.使用前列腺特异性抗原密度来提高前列腺特异性抗原在检测前列腺癌中的敏感性。
Cancer. 1994 Dec 1;74(11):2991-5. doi: 10.1002/1097-0142(19941201)74:11<2991::aid-cncr2820741116>3.0.co;2-r.
3
The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.筛查试验在前列腺癌检测中的价值。第二部分:游离/总前列腺特异性抗原分析比值、年龄特异性参考范围及前列腺特异性抗原密度的回顾性分析
Urology. 1995 Dec;46(6):779-84. doi: 10.1016/S0090-4295(99)80343-4.
4
Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.伊朗健康男性血清前列腺特异性抗原、前列腺体积及前列腺特异性抗原密度的年龄特异性参考水平
Iran J Immunol. 2009 Mar;6(1):40-8.
5
Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges.
Urology. 1995 Jun;45(6):972-9. doi: 10.1016/s0090-4295(99)80117-4.
6
Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.基于社区的健康男性人群中的血清前列腺特异性抗原。特定年龄参考范围的建立。
JAMA. 1993 Aug 18;270(7):860-4.
7
Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.基于社区的健康日本男性人群中的血清前列腺特异性抗原:数值低于同龄白人男性。
Br J Urol. 1995 Mar;75(3):347-53. doi: 10.1111/j.1464-410x.1995.tb07347.x.
8
An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density.一种利用前列腺特异性抗原和前列腺特异性抗原密度在患者群体中检测前列腺癌的算法。
World J Urol. 1993;11(4):206-13. doi: 10.1007/BF00185070.
9
Correlation of prostate-specific antigen and prostate-specific antigen density with outcome of prostate biopsy.前列腺特异性抗原及前列腺特异性抗原密度与前列腺活检结果的相关性
Urology. 1994 Feb;43(2):191-6. doi: 10.1016/0090-4295(94)90043-4.
10
Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project.具有成本效益的前列腺癌检测。减少低收益活检。美国癌症协会国家前列腺癌检测项目的研究人员。
Cancer. 1994 Dec 15;74(12):3146-58. doi: 10.1002/1097-0142(19941215)74:12<3146::aid-cncr2820741214>3.0.co;2-z.

引用本文的文献

1
Determining age-specific prostate-specific antigen for healthy Indian men: A retrospective study.确定健康印度男性的年龄特异性前列腺特异性抗原:一项回顾性研究。
Indian J Urol. 2023 Oct-Dec;39(4):317-321. doi: 10.4103/iju.iju_244_23. Epub 2023 Sep 29.
2
Age-specific percentile-based prostate-specific antigen cutoff values predict the risk of prostate cancer: A single hospital observation.基于年龄百分位数的前列腺特异性抗原临界值可预测前列腺癌风险:一项单中心医院观察研究。
Biomedicine (Taipei). 2023 Sep 1;13(3):9-24. doi: 10.37796/2211-8039.1415. eCollection 2023.
3
Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection.

本文引用的文献

1
Biopsy of men with PSA level of 2.6 to 4.0 ng/mL associated with favorable pathologic features and PSA progression rate: a preliminary analysis.前列腺特异性抗原(PSA)水平为2.6至4.0 ng/mL且具有良好病理特征和PSA进展率的男性患者活检:一项初步分析。
Urology. 2005 Sep;66(3):547-51. doi: 10.1016/j.urology.2005.03.093.
2
Relationship between prostate specific antigen and indexes of prostate volume in Japanese men.日本男性前列腺特异性抗原与前列腺体积指标之间的关系。
J Urol. 2005 Feb;173(2):503-6. doi: 10.1097/01.ju.0000148907.92910.4d.
3
Age-specific reference ranges for serum prostate-specific antigen.
用于侵袭性前列腺癌检测的尿液前列腺特异性抗原和血清前列腺特异性抗原
Cancers (Basel). 2023 Feb 2;15(3):960. doi: 10.3390/cancers15030960.
4
Raised prostate-specific antigen alone may not be a true predictor in high-risk prostate cancer: A retrospective cohort analysis.单纯前列腺特异性抗原升高可能并非高危前列腺癌的真正预测指标:一项回顾性队列分析。
Indian J Urol. 2022 Jan-Mar;38(1):22-28. doi: 10.4103/iju.iju_368_21. Epub 2022 Jan 1.
5
Identification of FAM107A as a potential biomarker and therapeutic target for prostate carcinoma.鉴定FAM107A作为前列腺癌的潜在生物标志物和治疗靶点。
Am J Transl Res. 2021 Sep 15;13(9):10163-10177. eCollection 2021.
6
Serum PSA levels in the Indian population: Is it different?印度人群的血清前列腺特异性抗原水平:有差异吗?
Med J Armed Forces India. 2017 Apr;73(2):112-117. doi: 10.1016/j.mjafi.2016.10.004. Epub 2016 Nov 30.
7
Serum PSA levels in Indian population. Is it really different?印度人群的血清前列腺特异性抗原水平。它真的有差异吗?
Med J Armed Forces India. 2017 Jul;73(3):315-316. doi: 10.1016/j.mjafi.2017.06.007. Epub 2017 Jul 27.
8
Demography and disease characteristics of prostate cancer in India.印度前列腺癌的人口统计学和疾病特征。
Indian J Urol. 2016 Apr-Jun;32(2):103-8. doi: 10.4103/0970-1591.174774.
9
A hospital based study on reference range of serum prostate specific antigen levels.一项基于医院的血清前列腺特异性抗原水平参考范围的研究。
Indian J Med Res. 2014 Oct;140(4):507-12.
10
Reference range of serum prostate-specific antigen levels in Indian men.印度男性血清前列腺特异性抗原水平的参考范围。
Indian J Med Res. 2014 Oct;140(4):480-1.
血清前列腺特异性抗原的年龄特异性参考范围。
Urol Clin North Am. 1997 May;24(2):339-51. doi: 10.1016/s0094-0143(05)70381-5.
4
Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.基于社区的健康男性人群中的血清前列腺特异性抗原。特定年龄参考范围的建立。
JAMA. 1993 Aug 18;270(7):860-4.
5
Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.基于社区的健康日本男性人群中的血清前列腺特异性抗原:数值低于同龄白人男性。
Br J Urol. 1995 Mar;75(3):347-53. doi: 10.1111/j.1464-410x.1995.tb07347.x.
6
Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.前列腺特异性抗原密度:一种区分良性前列腺增生和前列腺癌的方法。
J Urol. 1992 Mar;147(3 Pt 2):815-6. doi: 10.1016/s0022-5347(17)37393-7.